echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Antitumor Therapy > Full of dry goods!

    Full of dry goods!

    • Last Update: 2021-06-17
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    ▎The content team editor of WuXi AppTec recently, at an investor event held during the ASCO annual meeting, Roche gave a detailed introduction to the company's oncology R&D pipeline
    .

    It includes not only the Phase 3 clinical trial results of the blockbuster PD-L1 inhibitor Tecentriq as an adjuvant therapy for early non-small cell lung cancer (NSCLC) patients announced at the ASCO annual meeting, but also a number of early and late-stage research and development projects, involving The bispecific antibody platform R&D pipeline, drug development targeting the RAS signaling pathway, and the R&D layout of a new generation of immunotherapy are full of dry goods
    .

    Today, WuXi AppTec's content team will share the highlights of this report with readers
    .

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Related Articles

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.